导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 8.36% | 823/4773 |
| 近一周 | -3.23% | 3920/5462 |
| 近一月 | -8.63% | 4318/5421 |
| 近一季 | -13.00% | 3919/5209 |
| 近半年 | 5.19% | 782/4920 |
| 近一年 | 11.21% | 928/4366 |
| 近两年 | 109.46% | 484/2954 |
| 近三年 | 65.02% | 374/2253 |
| 成立以来 | 23.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.57% 3874/4961 |
51.99% 552/5312 |
- - |
- - |
| 2025 | 41.73% 724/4813 |
6.62% 607/3635 |
-2.30% 3342/4076 |
43.14% 663/4524 |
-4.94% 3498/4813 |
| 2024 | 12.08% 1273/3463 |
-2.63% 1394/2808 |
-2.33% 1177/3014 |
10.94% 2576/3129 |
6.24% 534/3463 |
| 2023 | -5.54% 750/2656 |
9.94% 390/2280 |
0.72% 281/2385 |
-10.31% 1983/2515 |
-4.89% 1203/2655 |
| 2022 | -29.76% 1614/2207 |
-22.38% 1698/1919 |
5.42% 903/2016 |
-16.10% 1402/2113 |
2.31% 978/2208 |
| 2021 | 18.31% 211/1822 |
-8.45% 1086/1255 |
20.72% 141/1330 |
-2.46% 575/1466 |
9.76% 111/1822 |
| 2020 | 64.32% 99/1250 |
2.61% 131/1022 |
26.51% 144/1060 |
8.77% 693/1152 |
- - |
| 2019 | 68.57% 30/1092 |
37.76% 67/748 |
-6.98% 530/797 |
15.18% 14/844 |
14.21% 21/912 |
| 2018 | -34.19% 567/834 |
- - |
- - |
- - |
-13.18% 514/691 |
| 2017 | -5.30% 510/714 |
- - |
- - |
- - |
- - |
| 2016 | -24.25% 469/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 富国中证工业4.0指数(LOF)A VS. 长安沪深300非周期A(740101) |